Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial
Top Cited Papers
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9293) , 1576-1585
- https://doi.org/10.1016/s0140-6736(01)06651-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Relationship between hospital volume and late survival after pancreaticoduodenectomySurgery, 1999
- A Surgical and Pathological Based Classification of Resective Treatment of Pancreatic CancerDigestive Surgery, 1999
- Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic unitsBritish Journal of Surgery, 1997
- Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomyInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre studyEuropean Journal Of Cancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Resection Margins in Carcinoma of the Head of the PancreasAnnals of Surgery, 1993
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990